Variant report
| Variant | nsv979590 | 
|---|---|
| Chromosome Location | chr21:15716014-15727420 | 
| allele | n/a | 
| Outlinks | Ensembl   UCSC | 
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data | 
| No data | 
          
 (count:3 , 50 per page) page: 
       
          
               
                   
                    1
                   
                   
                   
                   
                
          
         
    
    
                     
| No data | 
| No data | 
| No data | 
| No data | 
 Variant overlapped rSNPs/rCNVs (count:40 , 50 per page) page: 
                     
                        
                             
                                 
                                  1
                      Variant overlapped rSNPs/rCNVs (count:40 , 50 per page) page: 
                     
                        
                             
                                 
                                  1
                                 
                                 
                                 
                                 
                              
                        
                     
                 | No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits | 
|---|---|---|---|---|---|---|---|
| 1 | rs187185823 | chr21:15725610-15725611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 2 | rs2205254 | chr21:15725642-15725643 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a | 
| 3 | rs544123969 | chr21:15725657-15725658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 4 | rs141024831 | chr21:15725694-15725695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 5 | rs113998430 | chr21:15725702-15725703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 6 | rs540323978 | chr21:15725722-15725723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 7 | rs79439970 | chr21:15725733-15725734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 8 | rs559784664 | chr21:15725734-15725735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 9 | rs398101490 | chr21:15725735-15725736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 10 | rs528894066 | chr21:15725739-15725740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 11 | rs536268012 | chr21:15725744-15725745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 12 | rs571045596 | chr21:15725746-15725747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 13 | rs373563631 | chr21:15725805-15725806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 14 | rs532024385 | chr21:15725819-15725820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 15 | rs2822618 | chr21:15725868-15725869 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a | 
| 16 | rs571815528 | chr21:15725885-15725886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 17 | rs376667576 | chr21:15725933-15725934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 18 | rs527853374 | chr21:15725987-15725988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 19 | rs547884642 | chr21:15725996-15725997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 20 | rs13048016 | chr21:15726002-15726003 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance | 
| 21 | rs536672107 | chr21:15726093-15726094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 22 | rs190119533 | chr21:15726134-15726135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 23 | rs73157759 | chr21:15726155-15726156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 24 | rs2822619 | chr21:15726161-15726162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 25 | rs199684367 | chr21:15726173-15726174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 26 | rs113953828 | chr21:15726193-15726194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 27 | rs200806659 | chr21:15726299-15726300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 28 | rs538150688 | chr21:15726404-15726405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 29 | rs557718946 | chr21:15726412-15726413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 30 | rs577787519 | chr21:15726439-15726440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 31 | rs540041895 | chr21:15726443-15726444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 32 | rs8127673 | chr21:15726466-15726467 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a | 
| 33 | rs573400627 | chr21:15726486-15726487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 34 | rs141833220 | chr21:15726506-15726507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 35 | rs199772145 | chr21:15726522-15726523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 36 | rs150329079 | chr21:15726527-15726528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 37 | rs562154334 | chr21:15726539-15726540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 38 | rs182742837 | chr21:15726551-15726552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 39 | rs373638725 | chr21:15726559-15726560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| 40 | rs188719630 | chr21:15726581-15726582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a | 
| Disease | PMID | Source | 
|---|---|---|
| Ovarian cancer | 21720365 | CNVD | 
| Wilms tumour | 21544195 | CNVD | 
| Esophageal cancer | 21851588 | CNVD | 
| Glioblastoma multiforme | 21080181 | CNVD | 
| Cancer | 16751803 | CNVD | 
| Medulloblastoma | 21979893 | CNVD | 
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD | 
| Down syndrome | 17412756 | CNVD | 
| Down syndrome | 17576883 | CNVD | 
| Acute promyelocytic leukemia | 19109227 | CNVD | 
| T-cell prolymphocytic leukemia | 17713554 | CNVD | 
| Autism | 22495311 | CNVD | 
| Lung cancer | 18438408 | CNVD | 
| Acute lymphoblastic leukemia | 17690704 | CNVD | 
| Sudden cardiac death | 19188705 | CNVD | 
| T-cell prolymphocytic leukemia | 19278963 | CNVD | 
| Acute myeloid leukemia | 20729466 | CNVD | 
| Acute lymphoblastic leukemia | 20435627 | CNVD | 
| T-cell lymphomas | 19863542 | CNVD | 
| Non-small cell lung cancer | 21044232 | CNVD | 
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD | 
| Astrocytoma | 17387387 | CNVD | 
| Endometrial cancer | 22040021 | CNVD | 
| Breast cancer | 21264507 | CNVD | 
| Glioblastoma multiforme | 17387387 | CNVD | 
| Renal cell carcinoma | 19461508 | CNVD | 
| Seminomas | 18059402 | CNVD | 
| Chronic lymphocytic leukemia | 21546498 | CNVD | 
| Acute lymphoblastic leukemia | 21980252 | CNVD | 
| Metanephric adenoma | 20802469 | CNVD | 
| Neuroblastoma | 18923191 | CNVD | 
| Prostate cancer | 19156837 | CNVD | 
| Basal cell lymphoma | 17170743 | CNVD | 
| Follicular lymphoma | 17170743 | CNVD | 
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD | 
| Cancer | 20164919 | CNVD | 
| small cell lung cancer | 20016488 | CNVD | 
| Acute lymphoblastic leukemia | 21339820 | CNVD | 
| Breast cancer | 20409316 | CNVD | 
| Autism | 18414403 | CNVD | 
| Basal cell lymphoma | 16317097 | CNVD | 
| Diffuse large b-cell lymphoma | 16317097 | CNVD | 
| lymphocytic leukemia | 21291569 | CNVD | 
| Hodgkin''s lymphoma | 18641027 | CNVD | 
| Acute myeloid leukemia | 21251322 | CNVD | 
| abnormal development | 18461090 | CNVD | 
| Breast cancer | 21785460 | CNVD | 
| Breast cancer | 21364760 | CNVD | 
| Multiple myeloma | 17550852 | CNVD | 
| Myelofibrosis | 22110671 | CNVD | 
| Alzheimer''s disease | 18923514 | CNVD | 
| Alzheimer''s disease | 20877625 | CNVD | 
| Follicular lymphoma | 20505157 | CNVD | 
| Alzheimer''s disease | 21956041 | CNVD | 
| Cancer | 21183584 | CNVD | 
| Non-syndromic sensorineural hearing loss | 15273396 | CNVD | 
| Invasive pancreatic ductal carcinoma | 16982739 | CNVD | 
| Melanoma | 18172304 | CNVD | 
| Autism | 22958593 | CNVD | 
| Schizophrenia | 22958593 | CNVD | 
| No. | Chromosome Location | Chromatin state | Cell line | Tissue | 
|---|---|---|---|---|
| 1 | chr21:15725600-15726600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin | 
| 2 | chr21:15725800-15726000 | Enhancers | Fetal Stomach | stomach | 
| 3 | chr21:15726000-15726400 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood | 






